Dexamethasone
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Post-Surgical Ocular Pain
Conditions
Post-Surgical Ocular Pain, Post-Surgical Ocular Inflammation
Trial Timeline
Apr 1, 2014 → Mar 1, 2015
NCT ID
NCT02089113About Dexamethasone
Dexamethasone is a phase 3 stage product being developed by Ocular Therapeutix for Post-Surgical Ocular Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT02089113. Target conditions include Post-Surgical Ocular Pain, Post-Surgical Ocular Inflammation.
What happened to similar drugs?
0 of 3 similar drugs in Post-Surgical Ocular Pain were approved
Approved (0) Terminated (0) Active (3)
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (7)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04205916 | Approved | Recruiting |
| NCT02736175 | Phase 3 | Completed |
| NCT02988882 | Phase 3 | Completed |
| NCT02445326 | Phase 3 | Completed |
| NCT02468700 | Phase 2 | Completed |
| NCT02089113 | Phase 3 | Completed |
| NCT02062905 | Phase 2 | Completed |
Competing Products
5 competing products in Post-Surgical Ocular Pain
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Celecoxib | Astellas Pharma | Pre-clinical | 26 |
| Ibuprofen 250 mg / Acetaminophen 500 mg + Ibuprofen 250 mg + Acetaminophen 650 mg + Placebo | Pfizer | Phase 3 | 40 |
| valdecoxib + valdecoxib/placebo + placebo | Pfizer | Phase 3 | 40 |
| PF-04531083 + PF-04531083 + Ibuprofen | Pfizer | Phase 2 | 27 |
| Dexamethasone | Ocular Therapeutix | Phase 3 | 34 |